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Objective To assess the period during infancy and childhood in which growth is most associated with adolescent
adiposity and the metabolic syndrome (MS) and whether this differs depending on maternal smoking during preg-
nancy.
Study design A longitudinal population-based cohort study among 772 girls and 708 boys.
ResultsWeight gains between ages 2-4 years and ages 4-7 years weremost strongly associatedwith higher body
mass index (BMI), sum of skinfold measurements, body fat percentage, and waist circumference at age 16. A one
SD increase in weight between ages 2-4 and 4-7 years was associated with increases in outcome measures of
+0.82 to +1.47 SDs (all P < .001), and with a less favorable MS score. In children whose mothers smoked during
pregnancy, the association of relative weight gain during ages 2-4 years with adolescent BMI was stronger than
in children whose mothers did not smoke. For adolescent BMI, the increase was 0.42 SD higher (P = .01). This
was similar for the other adiposity measures.
Conclusions Large relative increases in weight from ages 2 to 7 years are associated with adolescent adipos-
ity and MS. This is more pronounced in adolescents whose mothers smoked during pregnancy. (J Pediatr
2013;162:287-92).
O
verweight is associated with an increased risk of cardiovascular morbidity, such as diabetes, hypertension, and dysli-
pidemia. These problems start in early life. It has been hypothesized that critical time periods exist in which accelerated
growth constitutes a risk factor for subsequent adiposity and its associatedmetabolic complications.1 Specifically, these
critical time periods include gestation, early infancy, the period of adiposity rebound, and adolescence. Systematic reviews have
shown consistently positive associations between rapid growth in early childhood (from birth to age 2 years and from age 2 to 7
years) and adolescent and adult overweight.2 Moreover, an early adiposity rebound has been found to be associated with adult
overweight, independent of the body mass index (BMI) at the start of the adiposity rebound.3
Strong evidence on the relative importance of these critical time period is lacking. This may be due to a scarcity of con-
temporary longitudinal population-based cohorts that include data on childhood weight gain.4 Moreover, most longitudinal
studies used only BMI as outcome measure. Although BMI is easy to obtain and very reliable, it does not differentiate be-
tween lean body mass and fat mass, whereas rapid weight gain in particular may lead to increased fat mass.5 A third, statis-
tical, problem concerns the collinearity of measurements during adjacent time periods, which creates challenges regarding the
relative importance of these time periods.6 Finally, the association between rapid weight gain in childhood and subsequent
adiposity may be affected by other variables that have not been included in previous studies. This concerns both potential
confounders, such as socioeconomic status (SES) and pubertal stage, and potential effect modifiers, such as smoking during
pregnancy.2,7 If not accounted for, these variables may affect study outcomes, which may have important implications for
targeting preventive measures.
The primary aim of our study was to assess the period during infancy and childhood in which growth is most associated with
adolescent adiposity and corresponding metabolic traits. Furthermore, we aimed to assess whether these associations differed
depending on maternal smoking during pregnancy.BF% B
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THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 162, No. 2registers and schools to obtain a representative sample of
the 3 northern provinces of The Netherlands. Three assess-
ment visits, which included weight and height measure-
ments, have been performed between 2001 and 2007, at
ages (mean  SD) of 11.1  0.6, 13.5  0.6, and
16.2  0.7 year. The response rate at the third assessment
was 83.0% (n = 1838) of the initial cohort. We included
children for whom growth data were available, leading
to the exclusion of 245 children. We restricted our analy-
ses to children born at term (37 weeks’ gestational age or
more), causing an additional 113 exclusions. This led to
a final sample of 1480 children. All procedures were ap-
proved by the Dutch Central Committee on Research In-
volving Human Subjects, including written informed
consent from parents or custodians.
Data on infant and childhood growth, including birth
weight and length, were extracted from records of well-
child clinics. These clinics are attended by 95% of the
Dutch population. Children attend at ages 1, 2, 3, 4, 6, 9,
11, 14, and 18 months and 2, 3, 4, 5, 10, and 13 years. Dur-
ing all visits, weight and length/height were measured by
trained nurses. At the Tracking Adolescents’ Individual
Lives Survey study assessment visits, weight and height
were measured with calibrated equipment (Models 770
and 214, respectively; Seca, Hamburg, Germany). In total,
18 (IQR 14-21) measurements of weight and height were
available per participant. From weight and height, BMI
(kg/m2) was calculated. We defined “overweight” and
“obesity” according to international age- and sex-adjusted
BMI criteria.9
At a mean age of 16.2 (0.68) years, skinfold thicknesses,
waist circumference (WC), and systolic and diastolic blood
pressures were measured. We performed hand-to-foot bio-
electrical impedance analysis to calculate body fat percentage
(BF%). For detailed information, we referred to a previous
study within the same cohort.10 Glucose, insulin, high-
density lipoprotein cholesterol, and triglyceride levels were
determined from a fasting blood sample. A composite score
for the metabolic syndrome (MS) was calculated as the
mean of z scores of glucose, insulin, high-density lipoprotein
cholesterol, triglycerides, WC, and mean blood pressure, cal-
culated within the study population.11
Infant feeding at age 3 months was reported by parents at
the well-child clinics. Information on maternal weight and
height and on smoking during pregnancy was obtained
through parental questionnaires when children were aged
11.1 years. This information on smoking during pregnancy
as obtained at child age 11.1 years showed good agreement
with data from the well-child clinics (k = .77).12 In addition,
questionnaires were filled out by child and parents regarding
pubertal stage (Physical Development Scale questionnaire),13
ethnicity, and SES. SES was calculated as the mean of SDS for
family income and mother’s and father’s level of education
and occupation based on the International Standard Classifi-
cation of Occupations.14 The 25% lowest, 50% intermediate,
and 25% highest were considered to represent low, medium,
and high SES, respectively.288Data Analyses
Weight, BMI, skinfold measurements, WC, systolic blood
pressure, insulin, and triglycerides were log-transformed to
obtain a better approximation of the normal distribution, be-
fore calculating age- and sex-specific SDSs.We also standard-
ized all available weight and BMI data. These were used to
construct growth curves from birth to age 15 years. Based
on previous literature,15-17 time periods were defined as birth
to 6 months, 6 months to 1 year, and 1-2, 2-4, 4-7, 7-11, and
11-15 years of age. We assumed that growth is characterized
by a straight line within each interval. These lines connect at
the breakpoints in age mentioned and visually resemble
a “broken stick.”18 The procedure resulted in 8 estimates
per person (1 for each breakpoint in age). Changes in scores
per period were calculated as the differences between the es-
timates at successive breakpoints in age.
In the analyses,we first assessed the association of changes in
weight relative to same-age peers (ie, in SDS from birth until
age 15 years), with the adiposity outcomes, using linear regres-
sion models. As outcomes we used BMI, skinfold measure-
ments, BF%, WC, and the composite score of the MS at age
16 years. In these analyses, we started by entering weight
SDS at the end of a certain age period. We then added change
in weight SDSwithin this age period to estimate the additional
effect of weight change during that period. We calculated the
increase in explained variance after adding the change in
weight to themodel. Larger increases in explained variance in-
dicate that the growth rate during this age period was more
strongly associated with adiposity outcomes, compared with
growth rates in other age periods. We performed stepwise
adjustments for pubertal stage, SES, birth weight, breastfeed-
ing until 3 months of age, smoking during pregnancy, and
maternal BMI. Only the latter 2 factors changed the effect sizes
significantly, and they were subsequently entered in an inter-
action analysis. Both variables seemed to modify the associa-
tions. In view of limiting the article, we chose to present only
the analyses regarding smoking during pregnancy because
this risk factor can be influenced during pregnancy; moreover,
maternal BMI was hampered by many missing values.
We repeated all analyses using changes in BMI SDSs as pre-
dictors, instead of changes in weight, with adjustment for
pubertal stage and SES, and with restriction to only white
children.
Individual parameters of the broken stickmodel were fitted
as randomly varying slopes in a linear multilevel model by use
of the S Plus 8.0 (TIBCO, Palo Alto, California) function
“lme.”19 All other statistical analyses were performed in
SPSS version 16.0 (SPSS Inc, Chicago, Illinois). The level of
statistical significance was set at P < .05. Our sample size
yielded a 90% power to detect an R2 of 0.007 attributed to
one independent variable in an F test with a = .05 (calculated
using PASS 11; NCSS, Kaysville, Utah).
Results
Our population consisted of 772 girls and 708 boys, with
a mean SD age at the last visit of 16.2 0.7 year. RegardingLiem et al
Figure 1. Weight SDS in normal weight versus overweight/
obese participants, by age. Differences between the 2 groups
are statistically significant at all time points (ie, P # .01).-,
Overweight/obese (n = 214);C, normal weight (n = 1245).
February 2013 ORIGINAL ARTICLESsocial class, 22.2% were in a low, 48.2% were in a middle, and
29.7% were in a high SES category. Of the population, 88.4%
were white; 11.9% of our population was overweight, and
2.6% was obese (Table I). Changes in weight SDS over
time showed that participants who were overweight or
obese at age 16 years had a higher birth weight
SDS (B = .14; 95% CI, 0.09-0.19; P < .001), then grew
parallel to normal weight children until age 1 and later on
gradually crossed weight percentiles (Figure 1).
Relative weight gains in the age periods between 1 and 15
years were significantly associated with higher BMI, sum of
skinfold measurements, BF%, and WC at age 16 (Table II).
Weight gains from birth to 0.5 and from 0.5 to 1 year
of age were associated with lower anthropometric
measurements at age 16, but not in all analyses with
statistical significance (Table II). We found a consistent
pattern of large increases in explained variances of all
outcome measures by adding relative weight gains from 2
to 4 and 4 to 7 years (Table II and Figure 2). One SDS of
weight gain during these periods was associated with
increases of +0.82 to +1.47 SD in BMI, sum of skinfold
measurements, BF%, and WC at age 16 (all P < .001).
Weight gains between ages 2-4 and 4-7 years were also
associated with a higher MS score (Table II and Figure 3;
Figure 3 available at www.jpeds.com). Weight gains
between age 11-15 years were also associated with large
increases in explained variance of the MS score. After
adjustment for current BMI SDS, all estimates for the
MS score were substantially reduced to statistically
nonsignificant effects. Using gains in BMI SDS instead of
weight SDS yielded weaker, but significant, results: +0.42 to
+0.89 SD for the various adiposity measures (all P < .001)Table I. Sociodemographic, anthropometric, and
metabolic characteristics; data refer to age 16 years
unless otherwise indicated
n Value
Age, y 1480 16.2  0.68
Smoking in pregnancy, % yes* 1478 30.2
Birth weight, g 1216 3470 (3165-3780)
Pubertal stage, % in 3 categories† 1381 15.8/28.3/55.9
Weight, kg 1480 62.9 (57.1-69.9)
Height, cm 1480 174.0  9.0
BMI, kg/m2 1480 20.77 (19.18-22.62)
Overweight/obese, % 1473 11.9/2.6
Sum of skinfold measurements, mm 1464 47 (32-65)
Body fat, % 1433 28.3  5.7
WC, cm 1458 73.8 (69.9-78.7)
Systolic blood pressure, mm Hg 1458 116 (110-127)
Diastolic blood pressure, mm Hg 1458 61  7
Glucose, mM 870 4.54  0.40
Insulin, mU/L 861 12.0 (9.2-16.0)
Triglycerides, mM 868 0.68 (0.51-0.92)
High density lipoprotein cholesterol, mM 868 1.46  0.31
MS scorez 981 0.01  0.53
All data are given as mean  SD or median (IQR) unless otherwise indicated.
*Based on a parental questionnaire filled out at child age 11.1 years.
†Measured by the Physical Development Scale questionnaire, divided into pre/early pubertal,
midpubertal, and late/postpubertal.
zDefined according to international age- and sex-adjusted BMI criteria.15
Growth during Infancy and Childhood, and Adiposity at Age 16 Y(data not shown). Adjustment for pubertal stage and SES
had only minor effects on the results (<10% in the
statistically significant associations; data not shown), which
was similar for analyses restricted to white children
(n = 1309, 88.4%).
We evaluated smoking during pregnancy as potential ef-
fect modifier in the 2 age periods in which we found the
strongest associations between changes in weight (and
BMI) SDS and anthropometric measurements at age 16
years. This yielded significant interaction terms (P < .05)
for 7 of the 12 associations concerned (Table III; available
at www.jpeds.com).
Next, we constructed separate models for adolescents who
had been exposed to smoking during pregnancy and for ad-
olescents who had not. Associations between gain in weight/
BMI SDS and adiposity-related measures were consistently
stronger in participants whose mothers smoked during preg-
nancy than in participants whose mothers did not smoke
(B = .07-.42; P = .70-.01; Table III). For example, each
unit increase in weight SDS between 2 and 4 years was
associated with an increase of 1.72 (95% CI, 1.46-1.98) in
BMI SDS at age 16 in adolescents whose mothers smoked
during pregnancy, compared with 1.30 (95% CI, 1.11-1.49)
in the other adolescents (Binteraction term, .42, 95% CI, 0.10-
0.74). The growth curve for overweight/obese participants
at age 16 years who were exposed to smoking during
pregnancy showed that they started at a relatively lower
birth weight and grew faster between ages 2-7 years
(Figure 4; available at www.jpeds.com). However,
adjustment for birth weight as a continuous variable did
not alter the results substantially (<10% for all significant
interactions; not shown). Also, adjustment for SES (both as
a categorical and as a continuous variable), breastfeeding at
3 months of age, and pubertal stage did not affect our
findings in the age period of 2-7 years (<10% for all
significant interactions; not shown).ears: Ages 2 to 7 Years Are Pivotal 289
Table II. Associations between weight SDS changes and anthropometric and metabolic traits at 16 years of age
Age period
Changes in weight SDS
Bweight change (95% CI) Pweight change
D explained variance, P
BMI SDS* (n = 1480) SF SDS* (n = 1464) BF% SDS (n = 1433) WC SDS* (n = 1458) MS SDS (n = 981)
0-0.5 y 0.07 (0.12 to 0.01) 0.06 (0.12 to 0.01) 0.02 (0.08 to 0.04) 0.07 (0.12 to 0.01) 0.01 (0.05 to 0.03)
.003, .02 .003, .03 <.001, .49 .003, .02 <.001, .68
0.5-1 y 0.07 (0.17 to 0.02) 0.13 (0.22 to 0.03) 0.07 (0.17 to 0.03) 0.10 (0.20 to 0.01) 0.03 (0.09 to 0.03)
.001, .14 .004, .01 .001, .17 .003, .03 .001, .34
1-2 y 0.78 (0.62 to 0.94) 0.53 (0.36 to 0.71) 0.60 (0.42 to 0.77) 0.65 (0.49 to 0.82) 0.18 (0.07 to 0.29)
.048, <.001 .022, <.001 .028, <.001 .034, <.001 .009, .002
2-4 y 1.47 (1.32 to 1.63) 1.24 (1.07 to 1.42) 1.30 (1.12 to 1.48) 1.29 (1.14 to 1.45) 0.49 (0.36 to 0.61)
.145, <.001 .101, <.001 .113, <.001 .112, <.001 .053, <.001
4-7 y 1.11 (0.97 to 1.25) 1.08 (0.92 to 1.24) 1.18 (1.02 to 1.34) 0.82 (0.57 to 0.96) 0.37 (0.26 to 0.48)
.089, <.001 .083, <.001 .101, <.001 .048, <.001 .035, <.001
7-11 y 0.47 (0.36 to 0.57) 0.56 (0.43 to 0.68) 0.61 (0.48 to 0.73) 0.19 (0.08 to 0.31) 0.16 (0.06 to 0.25)
.023, <.001 .033, <.001 .04, <.001 .004, <.001 .009, .001
11-15 y 0.99 (0.88 to 1.10) 0.79 (0.64 to 0.94) 0.67 (0.51 to 0.83) 0.83 (0.70 to 0.96) 0.48 (0.36 to 0.60)
.061, <.001 .038, <.001 .027, <.001 .044, <.001 .048, <.001
B, regression coefficient (effect size) from linear regression analyses; SF, sum of skinfold measurements.
Effect sizes (95% CI), explained variances, and P values are reported from multiple linear regression analyses adjusted for weight at the end of the period.
Large changes in explained variances are in bold.
*Data was log-transformed before calculation of SD scores to obtain a better approximation of the normal distribution.
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Our study confirms findings from previous studies, but now
in a large community-based cohort that covered a much
wider age range. Earlier reports covered periods after birth
that range from 21 months to 7 years, which were analyzed
in relation to adult overweight.20-22 Childhood growth had
a stronger association than infant growth regarding adult
BMI, fatness, and WC. A Finnish study on growth from
birth to age 13 years yielded a similar finding, showing
that growth started to deviate at age 2-3 for children who
were overweight at age 13 years.23 De Kroon et al24 also
identified the age period of 2-6 years as the most critical
in the development of adult overweight, using a similarFigure 2. Increase in explained variance by adding change in
weight SDS during the age period to predict BMI at age 16
years.
290methodology as the current study but with much lower re-
sponse rates.
We found that a higher relative weight gain in the first year
of life was associated with lower values on adolescent adipos-
ity measures, whereas earlier studies found a higher gain to be
associated with higher values but only assessed growth in the
first year.2 However, the association between infant growth
and overweight in later life has been disputed by other studies
that did not find any association between infancy weight gain
and later fatness.20,25
Adolescents with overweight at age 16 years had a higher
birth weight than normal-weight adolescents, at age 16 years.
This is consistent with previous studies that showed an asso-
ciation between high birth weight and increased risk of sub-
sequent overweight.26
We decided to present changes in weight SDS as the pre-
dictor in our Tables and Figures, because these models fit
surprisingly better than the models with changes in BMI
SDS as predictor (explained variances of 3.5%-14.5% for
weight SDS vs 2.2%-7.1% for BMI SDS in the age periods
between 2 and 7 years, for the various outcome measures).
A possible explanation is the fact that we use BMI SDS.
Height determines BMI in an important way and is highly
correlated with age. BMI SDS is calculated to correct for
age. This might lead to overcorrection for age, which could
reduce the power of changes in BMI SDS to predict
measures of overweight at age 16 years.
The association between childhood weight gain and ado-
lescent adiposity was stronger in the case of exposure to
smoking during pregnancy. Exposed children also had a lower
birth weight, but adjustment for birth weight did not affect
this association, suggesting that birth weight per se does
not explain the modifying effect of smoking during preg-
nancy. Others have found a similar influence of smoking dur-
ing pregnancy, which also was independent of SES although
in a relatively homogeneously financially secure cohort.7 ThisLiem et al
February 2013 ORIGINAL ARTICLESmakes a socioeconomic explanation for these and our find-
ings less likely. Another explanation for the moderating effect
of intrauterine smoking exposure is a difference in lifestyle
among children whose parents smoke. For example, nutrient
intake and physical activity levels could vary between house-
holds in which parents smoke.27
Next to smoking during pregnancy, we evaluated maternal
BMI as a potential effect modifier. We found significant in-
teraction terms in all except 2 models (these exceptions
were weight SDS change between 4 and 7 years in predicting
skinfold measurements and BF%, P = .20 and .17, respec-
tively) with effect sizes of 0.04-0.08 (P = .03 to <.001), sug-
gesting that in children of mothers with a higher BMI, the
association between weight gain from age 2-7 years and mea-
sures of adolescent overweight is stronger. As mentioned in
the Methods section, we decided to focus on smoking during
pregnancy because this risk factor is more amenable to
change.
The main strengths of our study are the multiple measure-
ments of weight and height from early infancy to adolescence
available in a large contemporary cohort with high response
rates. Furthermore, we included various measures of overall
and abdominal adiposity at age 16 and various potential con-
founders and modifiers. A potential limitation may be that
the measurements of weight and height had been performed
by various professionals in the well-child clinics. This may
have added measurement error, and thus have led to an un-
derestimation of the strength of the associations. However,
others have described robust findings using such routine ex-
aminations.28 Another potential limitation is that we per-
formed multiple statistical tests. Note that these concerned
correlated outcome measures. A partial Bonferroni correc-
tion to adjust for this would lead to a significance level of
.02. Use of this stricter significance level does not alter our
conclusions. Moreover, the power achieved by our sample
size of detecting an R2 of 0.007 is still high, 82%, at an a of
.02. Finally, compared with populations in the US and the
United Kingdom, relatively few adolescents were obese at
age 16 years. Caution is required in extrapolating our conclu-
sions to other populations with a high prevalence of severe
obesity.
We found that increases in weight and BMI SDS between
ages 2 and 7 years are associated with overall and abdominal
adiposity in adolescence. In adolescents whose mothers
smoked during pregnancy, the influence of weight gain dur-
ing these years is more pronounced. Our findings support
an early start of preventive strategies, as early as 2 years of
age. Moreover, interventions should especially target chil-
dren whose mothers smoked during pregnancy. This offers
important clues for interventions to contain the overweight
epidemic. n
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tional studies. BMJ 2001;322:326-8.A Chromosome Anomaly in an Infant with a Degenerative Disease of the Central
Nervous System
Bray P, Mukherjee B. J Pediatr 1963;62:230-4
Fifty years ago, Bray and Mukherjee described an infant with microcephaly, severe spastic quadriparesis, impairedgag, slow neurologic deterioration, and episodes of infection and dehydration. Pneumoencephalography revealed
ex vacuo ventriculomegaly and electroencephalography demonstrated decreased background amplitude. The karyo-
type showed a balanced reciprocal translocation of chromosomes 16 and 17, the first time a translocation of chro-
mosomes 16-18 had been reported. The finding was also novel because balanced translocations were previously
presumed to be asymptomatic. Presciently, the authors postulated that this case may not actually represent a balanced
translocation, as the “naked-eye method of karyotype analysis may fail to detect the loss of small amounts of genetic
material.”
G-banded karyotyping was the first-line genetic test for approximately 40 years, advantageous for its pictorial and
intuitive representation of the entire genome. Its disadvantages include the relative subjectivity of analysis, and the
failure to detect deletions/duplications of genetic material less than 5 million base pairs. With ongoing advancements
in DNA analysis, the chromosome microarray has now emerged as the first-step genetic test when no specific condi-
tion is suspected. This represents a sea change from a structural image (the karyotype) to a quantitative assessment
(copy number variant). In addition, the microarray can simultaneously detect copy number changes at multiple
loci in a genome, as compared with FISH analysis.
There are various types of arrays, but all compare DNA from the patient and the control. This DNA, which can
either be “whole genome” or “targeted,” is labeled with either oligonucleotides, single nucleotide polymorphisms,
complementary DNAs, or bacterial artificial chromosomes. It thus follows that the smaller the size of the nucleic
acid targets and the greater the density of their coverage over the genome, the greater the resolution power of the
microarray. Also, as microarrays becomemore powerful the finding of results of “uncertain significance” will increase.
Previously unreported deletions/duplications will need to be archived and, once sufficient cases are collected, catego-
rized as pathogenic or benign. This is a task that the International Standard Cytogenomic Array Consortium is inves-
tigating. Compared with 50 years ago, the chromosome microarray is a powerful genetic tool in our armamentarium.
Susy Jeng, MD
Division of Child Neurology
Stanford University
Stanford, California
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175.010.2003.005), the Sophia Foundation for Medical Re-
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project FP-006), and the participating universities, which in-
clude various departments of the University Medical Center
and University of Groningen, the Erasmus University Medi-
cal Center Rotterdam, the University of Utrecht, the Rad-
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group, all in the Netherlands. The sponsors had no influence
in: (1) study design; (2) the collection, analysis, and interpre-
tation of data; (3) the writing of the report; or (4) the decision
to submit the paper for publication.
Table III. Smoking during pregnancy as potential effect modifier in the associations between weight changes and
anthropometric traits at 16 years of age
BMI SDS* (n = 1593) SF SDS* (n = 1573) BF% SDS (n = 1543) WC SDS* (n = 1589)
Weight change 2-4 y (SDS)
Binteraction (95% CI), Pinteraction .42 (.10 to .74), .01 .28 (.07 to .64), .12 .33 (.03 to .69), .08 .39 (.07 to .72), .02
Bweight change (95% CI), Pweight change in model
for nonsmoking exposure
1.30 (1.11 to 1.49), <.001 1.12 (.91 to 1.33), <.001 1.16 (.94 to 1.38), <.001 1.13 (.94 to 1.32), <.001
Bweight change (95% CI), Pweight change in model
for smoking exposure
1.72 (1.46 to 1.98), <.001 1.40 (1.11 to 1.69), <.001 1.49 (1.19 to 1.78), <.001 1.53 (1.26 to 1.79), <.001
Weight change 4-7 y (SDS)
Binteraction (95% CI), Pinteraction .22 (.07 to .50), .14 .18 (.14 to .51), .27 .07 (.27 to .40), .70 .38 (.08 to .68), .01
Bweight change (95% CI), Pweight change in model
for nonsmoking exposure
1.01 (.84 to 1.18), <.001 1.00 (.80 to 1.19), <.001 1.13 (.94 to 1.33), <.001 .66 (.49 to .84), <.001
Bweight change (95% CI), Pweight change in model
for smoking exposure
1.22 (.99 to .07), <.001 1.18 (.91 to 1.45), <.001 1.20 (.93 to 1.47), <.001 1.04 (.80 to 1.29), <.001
BMI change 4-7 y (SDS)
Binteraction (95% CI), P interaction .38 (.15 to .61), .001 .46 (.16 to .76), .002 .37 (.08 to .67), .01 .56 (.27 to .85), <.001
BBMI change (95% CI), PBMI change in model for
nonsmoking exposure
.67 (.55 to .79), <.001 .73 (.57 to .89), <.001 .77 (.61 to .93), <.001 .52 (.36 to .68), <.001
BBMI change (95% CI), PBMI change in model for
smoking exposure
1.05 (.85 to 1.25), <.001 1.19 (.94 to 1.45), <.001 1.14 (.89 to 1.40), <.001 1.08 (.83 to 1.33), <.001
Effect sizes (95% CI), and P values are reported from multiple linear regression analyses adjusted for BMI at the end of the period.
Similar results were obtained after adjustment for pubertal stage and SES.
*Log-transformed before calculation of SD scores to obtain a better approximation of the normal distribution.
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Figure 3. Weight SDS for 2 groups of participants, with an
MS score >+1 SD and #+1 SD, by age. Differences between
the 2 groups are statistically significant at all time points from
age 2 (ie, P# .01).-, Participants with an MS score >+1 SD;
C, participants with an MS score of #+1 SD.
Figure 4. Weight SDS in overweight/obese versus normal
weight participants whose mothers did or did not smoke dur-
ing pregnancy, by age. In the group whose mothers did not
smoke, differences between the overweight/obese and nor-
mal weight participants are statistically significant at all time
points (ie, P # .005). In the group whose mothers did smoke,
differences between the overweight/obese and normal weight
participants are statistically significant at all time points
except age 0.5 year (ie, P # .017). V, Overweight/obese and
smoking mother during pregnancy (n = 87); -, overweight/
obese and nonsmoking mother during pregnancy (n = 127);
C, normal weight and nonsmoking mother during pregnancy
(n = 888); D, normal weight and smoking mother during preg-
nancy (n = 355).
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